BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 27257182)

  • 1. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.
    Moschoi R; Imbert V; Nebout M; Chiche J; Mary D; Prebet T; Saland E; Castellano R; Pouyet L; Collette Y; Vey N; Chabannon C; Recher C; Sarry JE; Alcor D; Peyron JF; Griessinger E
    Blood; 2016 Jul; 128(2):253-64. PubMed ID: 27257182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
    Marlein CR; Zaitseva L; Piddock RE; Robinson SD; Edwards DR; Shafat MS; Zhou Z; Lawes M; Bowles KM; Rushworth SA
    Blood; 2017 Oct; 130(14):1649-1660. PubMed ID: 28733324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells.
    You R; Wang B; Chen P; Zheng X; Hou D; Wang X; Zhang B; Chen L; Li D; Lin X; Huang H
    Cancer Lett; 2022 Apr; 532():215582. PubMed ID: 35122876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
    Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA
    Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells.
    Schuringa JJ; Schepers H
    Methods Mol Biol; 2009; 538():287-300. PubMed ID: 19277587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
    Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
    J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
    Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
    Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
    Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
    Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
    Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
    Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
    Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
    Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro.
    Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C
    Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels.
    Glenjen NI; Hatfield K; Bruserud Ø
    Eur J Haematol; 2005 Jan; 74(1):24-34. PubMed ID: 15613103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
    Garrido SM; Appelbaum FR; Willman CL; Banker DE
    Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
    Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ
    Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
    Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia.
    Piya S; Kornblau SM; Ruvolo VR; Mu H; Ruvolo PP; McQueen T; Davis RE; Hail N; Kantarjian H; Andreeff M; Borthakur G
    Blood; 2016 Sep; 128(9):1260-9. PubMed ID: 27268264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.